The Latest News
-
The longstanding collaboration between the two organizations aims to combat this growing biomedical crisis by improving the way we treat with antibiotics. -
Children's Health
From child neurology to stem cells: An interview with Evan Snyder
In honor of his recent inclusion in a notable neurology textbook, we interviewed Sanford Burnham Prebys Professor Evan Snyder about how his work in child neurology and social work informed his foundational discoveries in the early history of stem cell research. -
Researchers from Sanford Burnham Prebys have been recognized for their influence on the progress of science by being included on Clarivate's 2021 Highly Cited Researchers list. -
Genetic Disorders and Aging
Sanford Burnham Prebys unravels mysteries of the aging Down syndrome brain
A landmark brain study led by Jerold Chun, M.D. Ph.D., is helping reveal why individuals with Down syndrome inevitably get Alzheimer's as they age. -
Researchers from Sanford Burnham Prebys and the NCI have shown that CRISPR gene editing may favor cells with certain cancer-linked mutations. -
Rather than killing tumors outright, the novel approach starves cancer cells of the nutrients they need to grow. -
By deactivating the cells that sustain tumors, researchers from Sanford Burnham Prebys are working to treat one of the deadliest brain cancers. -
Svasti Haricharan, a Sanford Burnham Prebys assistant professor and Karen McDonald, an advocate working with Svasti's team, discuss how to include patient voices in the biomedical research process. -
Researchers from Sanford Burnham Prebys recently published a review article in the journal Cell about cytoplasmic DNA. This is DNA that has migrated outside of the nucleus, which can act as a short-term protective strategy against cancer formation. However, the DNA can also contribute to cancer development through chronic inflammation over the long term. -
Children's Health
This enzyme is one of the hardest working proteins in the body
Researchers led by Yu Yamaguchi, M.D., Ph.D., have shown that in the absence of a certain protein, levels of an important carbohydrate increase to up to 40 times their usual level. -
Researchers from Sanford Burnham Prebys including Evan Snyder, M.D., Ph.D., Pier Lorenzo Puri, M.D. and Alessandra Sacco, Ph.D. have received $5 million in new funding to launch a multidisciplinary stem cell training program, with an addition $10 million going to researchers at other San Diego research institutes. -
Children's Health
New stem cell identified by Sanford Burnham Prebys researchers offers hope to people with rare liver disease
Elusive liver stem cells found ‘outside the box’ offer a ray of light to people with Alagille syndrome.
Living History
NCI-Designated Cancer Center
Earning the NCI designation in 1981 — just five years after its modest start in downtown La Jolla — our Cancer Center truly is "the miracle on Torrey Pines Mesa."
Next Generation
Victoria Blaho receives prestigious Lina M. Obeid Award
Victoria Blaho, Ph.D., assistant professor in the Immunity and Pathogenesis Program, has received the first-ever Lina M. Obeid Award for her promising research on the biology of sphingolipids.
Living History
Along the road to discovery
It was in 1979 when Eva Engvall asked Erkki Ruoslahti a question that would change their lives forever: "Wouldn't it be great to work in San Diego?"
Next Generation
Graduate student Katja Birker's research doesn't miss a beat
"There is no magic wand to cure congenital heart conditions–we have to do the research."
COVID-19 matching gift campaign
The power of investing in human health
Dinah Ruch is accelerating our COVID-19 efforts with a generous matching gift that doubles all donations dollar for dollar up to $500,000.
Our Partners in Discovery
We can't do it alone
Our annual Rare Disease Day symposium strengthens the global network of families, physicians and researchers to better understand and fight rare diseases in children.
Our Partners in Discovery
Getting to the finish line faster
Thanks to the philanthropic vision of Stuart and Karen Tanz, a unique collaboration seeks new treatments for diseases such as Alzheimer’s, dementia and Parkinson’s.
Our Partners in Discovery
New hope for autoimmune disease
Our partnership with Lilly—centered around a high degree of interaction—has already produced an immune therapy now in clinical trial.
Our Partners in Discovery
A master class in collaboration
Meet T. Denny Sanford, Conrad Prebys and Malin Burnham: three people who know we're stronger when we work together.
